Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Manipal Health Enterprises's EBIT per Share for the
six
months ended in Mar. 2026 was ₹16.07.
Manipal Health Enterprises does not have enough years/quarters to calculate its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026.
During the past 12 months, the average EBIT per Share Growth Rate of Manipal Health Enterprises was 14.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Manipal Health Enterprises's EBIT per Share or its related term are showing as below:
NSE:MANIPALHOS's 3-Year EBIT Growth Rate is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 11.6 * Ranked among companies with meaningful 3-Year EBIT Growth Rate only.
Manipal Health Enterprises (NSE:MANIPALHOS) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Manipal Health Enterprises EBIT per Share Related Terms
Manipal Health Enterprises EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Manipal Health Enterprises (NSE:MANIPALHOS) has a EBIT per Share of ₹ as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Manipal Health Enterprises and its competitors. According to the industry distribution chart, Manipal Health Enterprises ranks #999999 out of 524 companies in the Healthcare Providers & Services industry.
Is Manipal Health Enterprises' EBIT per Share too high?
Manipal Health Enterprises' current EBIT per Share is ₹. Based on the distribution chart, Manipal Health Enterprises ranks #999999 out of 524 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Manipal Health Enterprises has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Manipal Health Enterprises' EBIT per Share compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Manipal Health Enterprises ranks #999999 out of 524 companies for EBIT per Share. This places Manipal Health Enterprises in the lower half of its industry. The industry median EBIT per Share is 11.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 11.60, based on 524 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Manipal Health Enterprises and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 11.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Manipal Health Enterprises's current EBIT per Share is ₹. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Manipal Health Enterprises stock overvalued right now?
Manipal Health Enterprises (NSE:MANIPALHOS) has a current EBIT per Share of ₹. The current EBIT per Share is ₹. Manipal Health Enterprises' overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Manipal Health Enterprises (NSE:MANIPALHOS), the current EBIT per Share is ₹ as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Manipal Health Enterprises Ltd is engaged in the business of running/managing hospitals and providing healthcare services. The company operates through various Hospitals/clinics providing Healthcare services and diagnostic centres in India. It offers clinical services across several specialties, with a focus on tertiary and quaternary care, particularly in cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics, and renal sciences. It has a single business segment, namely engaged in the business of healthcare services. The company generates revenue by providing inpatient care at its hospitals.
13GF Score
Get the complete analysis for NSE:MANIPALHOS
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MANIPALHOS has been successfully added to your 
